Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02410720
Other study ID # IM.AS1.35
Secondary ID
Status Completed
Phase N/A
First received July 10, 2013
Last updated December 28, 2015
Start date June 2013
Est. completion date July 2015

Study information

Verified date December 2015
Source American University of Beirut Medical Center
Contact n/a
Is FDA regulated No
Health authority Lebanon: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Colonoscopy is the preferred procedure to investigate any large-bowel disease in adults and children. In addition, colonoscopy is the current gold standard for colorectal cancer screening due to its high diagnostic capabilities and its unique feature that permits sampling and removal of pathology. For optimal performance and visualization of details, however, an adequate bowel preparation is essential. Inadequate bowel preparation is associated with cancelled procedures, prolonged procedure time, incomplete examination, increased cost and possibly complications, physician frustration and patient anxiety, but most importantly serving to impede colorectal cancer screening and surveillance.

A good bowel preparation would need a solution with a reasonable volume, acceptable taste, minimal diet restrictions, and easy to follow instructions; and would also need patients' adherence to the instructions and diet restrictions. Noncompliance of patients to the diet restrictions, the starting day of diet, the timing of drinking the solution, and other instructions play an important role in rendering the colon preparation inadequate.

Aim: The investigators aim, at assessing the influence of having a reminder mobile application on the compliance and adherence to instructions and diet and consequently on the quality of colon preparation.

Hypothesis: The investigators' hypothesis is that patients having a customized mobile App reminding them systematically about instruction and time of intake of the preparation will have a better adherence to the prep protocol and likely on the quality preparation than those given written and verbal instructions in clinic.


Description:

This is a randomized controlled trial that will include patients undergoing elective colonoscopy at the American University of Beirut Medical Center. Patients will be randomized into one of two study arms using a computer generated randomization list. 160 patients will be enrolled in total. All patients will be instructed by the study coordinator on the importance of adherence to the protocol in the leaflet emphasizing its importance to the colonoscopy quality. In addition, patients in Arm 2 will be given information about the application features. The application will have push notifications to inform patient on time of start of dietary changes, type of diet, time of preparing the solution, time of drinking the solution, reminder of their appointment, etc. All patients will then be interviewed by the research coordinator to evaluate the adherence to the assigned diet and compliance with the prep protocol as the main outcome and the ease of the application and the patient's attitude towards having such application as secondary outcomes. Based on the results of similar studies that assessed the use of software system to improve compliance, the investigators' sample size was a calculated assuming similar results. Calculations showed that 78 patients per arm will be enough to attain significance. The number 80 was chosen as attrition is presumed to be low. As for the statistical analysis, SPSS version 20.0 will be used for data entry and analysis.


Recruitment information / eligibility

Status Completed
Enrollment 160
Est. completion date July 2015
Est. primary completion date March 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Elective outpatient colonoscopy

- Consent to the study

- Owning a smartphone

Exclusion Criteria:

- Pregnant or lactating women

- Age less than 18 years

- Known Inflammatory bowel disease

- Significant gastroparesis

- Gastric outlet obstruction

- Ileus

- Known or suspected bowel obstruction or perforation

- Phenylketonuria

- Toxic colitis or megacolon

- Having a stoma

- Compromised swallowing reflex or mental status

- Psychiatric disease or known or suspected poor compliance

- Severe chronic renal failure (creatinine clearance <30 mL/minute)

- Severe congestive heart failure (New York Heart Association [NYHA] class III or IV)

- Dehydration

- Laxative use or dependency

- Chronic constipation (<3 spontaneous bm/week)

- Uncontrolled hypertension (systolic blood pressure =170 mm Hg, diastolic blood pressure =100 mm Hg)

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Other:
Instruction leaflet
Patients will receive the Picoprep solution with an instruction leaflet of how to use it and the dietary modifications needed
Mobile App
Patients will receive Picoprep solution with an instruction leaflet + Picoprep Mobile App which will be downloaded to their smartphones that has the same information plus a reminder utility
Explanation of paper and application instructions
The research fellow will explain instructions to patients
Picoprep solution


Locations

Country Name City State
Lebanon American University of Beirut Medical Center Beirut

Sponsors (1)

Lead Sponsor Collaborator
American University of Beirut Medical Center

Country where clinical trial is conducted

Lebanon, 

Outcome

Type Measure Description Time frame Safety issue
Primary Quality of the preparation using the modified Aronshick scale During every colonoscopy a blinded interventionalist will assess the quality of the preparation using the modified Aronshick scale Directly after the Colonoscopy No
Primary Questionnaire for adherence to the assigned diet The research coordinator will ask the patients specific questions to assess their adherence to the assigned diet ( first and second dietary changes) 30 minutes before the Colonoscopy No
Primary Questionnaire for compliance with the prep protocol The research coordinator will ask the patients specific questions to assess their compliance with the prep protocol 30 minutes before the Colonoscopy No
Secondary Patient satisfaction with the written instructions and mobile application using a visual analogue scale Patient satisfaction will be assessed using a visual analogue scale 30 minutes before the Colonoscopy No
Secondary Questionnaire for ease of use of the mobile App Patients will be asked about the ease of use of the mobile App 30 minutes before the Colonoscopy No
Secondary Questionnaire for patient willingness to take the same preparation in the future if needed Patients will be asked about their willingness to take the same preparation in the future if needed 30 minutes before the Colonoscopy No
See also
  Status Clinical Trial Phase
Terminated NCT01140295 - Bowel Preparation for Colonoscopy in Children Phase 4
Recruiting NCT03290157 - Improvement of Colonoscopy Preparation by Using a SPA N/A
Completed NCT04150133 - Effects and Tolerability With Clenpiq and Low Residue Diet N/A
Completed NCT01531140 - PEG Versus PEG+Bisacodyl Versus Sennosides for Colon Cleansing Before Colonoscopy Phase 4
Completed NCT06021639 - Comparison of Bowel Cleansing Regimens for Colonoscopy N/A
Completed NCT02073552 - Colon Cleansing Quality of Polyethylene Glycol Compared With Polyethylene Glycol Plus Ascorbic Acid. Phase 4
Completed NCT01596686 - Comparison of Preparation Regimens for Colonoscopy N/A
Withdrawn NCT04361656 - The Effect of Adding Lubiprostone to Standard Large-Volume PEG-ELS on The Quality of Inpatient Colonoscopy Preparation
Completed NCT01610856 - Single Dose Versus Split Dose Polyethylene Glycol-based Colonic Lavage for Colonoscopy N/A
Completed NCT01887470 - 2 Regimens of Lactulose for Colonoscopy Preparation in Adults Phase 2
Completed NCT06282367 - Bowel Preparation for Colonoscopy With Oral Lactulose
Completed NCT02304523 - Safety and Efficacy of CDFR0612 and CDFR0613 for Bowel Cleansing Before Colonoscopy Phase 3
Completed NCT06453655 - The Effect of Nurse Process on Bowel Cleansing N/A
Completed NCT02665624 - Adding Stewed Apricot Juice to Senna Improves the Right-Side and Overall Colon Cleansing Quality for Colonoscopy Preparation Phase 4
Completed NCT02123017 - Efficacy and Safety of Bisacodyl and Lactulose as a Preparation for Colonoscopy Phase 2